Wednesday, March 11, 2026 11:07:35 AM
THE DAY 51 REPORT: WHY THE FILINGS ARE "GHOSTING"
Intelligence Update: Wednesday, March 11, 2026
For weeks, people have asked: "If someone owns more than 3%, why hasn't a TR-1 form been filed?"
The answer is simple: They aren't hitting the trigger on purpose.
======================================================================
THE "STEALTH" MATH | RETAIL EXPECTATION | REGULATORY REALITY
======================================================================
THRESHOLD TRIGGER | 3.00% (Notification) | 2.99% (NO FILING)
SHARE COUNT LIMIT | 47.9 Million Shares | 47.8 Million (STAY UNDER)
TOTAL SHARES MOVED | "Waiting for news" | 1.6 BILLION (ACTUAL I/O)
VALUATION FLOOR | $0.23 (OTC Ticker) | $1.71 (LONDON REGISTRY)
======================================================================
HOW THE "SHELL GAME" WORKS:
Under UK Rule DTR 5, you only have to tell the public who you are if you hit 3%.
On a 1.6 Billion share company, that means you can hold 47 Million shares
and stay completely invisible. To move the massive 900 Million share block
we’ve seen, you just need 20 separate accounts holding 2.99% each.
THE TWO-PART PINCER:
1. MARCH 16 (Monday): The Delaware Court cancels 17% of the options.
(The "Ghost Supply" in the US is physically deleted).
2. MARCH 20 (Friday): The 60-day "Secret Window" (PRM 1.6.4R) expires.
The London Registry must reveal the total count.
THE BOTTOM LINE:
The reason the data went dark on March 10th isn't because they stopped
buying—it's because the Vault is Full. They are at the 2.99% limit
and are simply waiting for the clock to run out.
STOP LOOKING AT THE TICKER. START LOOKING AT THE CALENDAR.
Intelligence Update: Wednesday, March 11, 2026
For weeks, people have asked: "If someone owns more than 3%, why hasn't a TR-1 form been filed?"
The answer is simple: They aren't hitting the trigger on purpose.
======================================================================
THE "STEALTH" MATH | RETAIL EXPECTATION | REGULATORY REALITY
======================================================================
THRESHOLD TRIGGER | 3.00% (Notification) | 2.99% (NO FILING)
SHARE COUNT LIMIT | 47.9 Million Shares | 47.8 Million (STAY UNDER)
TOTAL SHARES MOVED | "Waiting for news" | 1.6 BILLION (ACTUAL I/O)
VALUATION FLOOR | $0.23 (OTC Ticker) | $1.71 (LONDON REGISTRY)
======================================================================
HOW THE "SHELL GAME" WORKS:
Under UK Rule DTR 5, you only have to tell the public who you are if you hit 3%.
On a 1.6 Billion share company, that means you can hold 47 Million shares
and stay completely invisible. To move the massive 900 Million share block
we’ve seen, you just need 20 separate accounts holding 2.99% each.
THE TWO-PART PINCER:
1. MARCH 16 (Monday): The Delaware Court cancels 17% of the options.
(The "Ghost Supply" in the US is physically deleted).
2. MARCH 20 (Friday): The 60-day "Secret Window" (PRM 1.6.4R) expires.
The London Registry must reveal the total count.
THE BOTTOM LINE:
The reason the data went dark on March 10th isn't because they stopped
buying—it's because the Vault is Full. They are at the 2.99% limit
and are simply waiting for the clock to run out.
STOP LOOKING AT THE TICKER. START LOOKING AT THE CALENDAR.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
